Back to search results

MB-CART19.1 in Refractory SLE

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

SLE - Systemic Lupus Erythematosus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Universitätsklinikum Erlangen, Medizinische Klinik 3, Erlangen, Germany

    Contact: Study coordinator (Georg Schett, Prof., Dr.)
    Contact: Study coordinator (Fabian Müller, PD, Dr.)

  • Otto-von-Guericke-Universität Magdeburg, Magdeburg, Germany

    Contact: Study coordinator (Dimitrious Mougiakakos, Dr.)
    Contact: Study coordinator (Eugen Feist, Prof., Dr.)

  • Universitatsklinikum Tubingen - Medizinische Universitätsklinik Abt. II, Tübingen, Germany

    Contact: Study coordinator (Jörg Henes, Prof., Dr.)
    Contact: Study coordinator (Wolfgang Bethge, Prof., Dr.)
Study leads

  • Georg Schett, Prof. Dr.

    Principal Investigator

    University Clinical Erlangen, Medical Clinic 3

View source on ClinicalTrials.gov(opens in a new tab)